Pharmacokinetics of iron isomaltoside 1000 in patients with inflammatory bowel disease

Kim Nordfjeld, Hans Andreasen, Lars L ThomsenPharmacosmos A/S, Holbaek, DenmarkBackground: Iron isomaltoside 1000 is a novel injectable iron compound which offers potential advantages in the treatment of subjects with iron-deficiency anemia. We studied the pharmacokinetics (PK) of this novel compoun...

Full description

Bibliographic Details
Main Authors: Nordfjeld K, Andreasen H, Thomsen LL
Format: Article
Language:English
Published: Dove Medical Press 2012-03-01
Series:Drug Design, Development and Therapy
Online Access:http://www.dovepress.com/pharmacokinetics-of-iron-isomaltoside-1000-in-patients-with-inflammato-a9395